Filtered By:
Condition: Hemorrhagic Stroke
Procedure: Angioplasty

This page shows you your search results in order of relevance. This is page number 9.

Order by Relevance | Date

Total 340 results found since Jan 2013.

Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise.
CONCLUSION: In this retrospective single-center study undersized balloon angioplasty and deployment of a self-expandable stent with relatively low radial force was safe and effective for endovascular treatment of high-grade intracranial arterial stenosis with high technical success rate, low periprocedural complication rates and favorable medium-term follow-up results. PMID: 30991867 [PubMed - as supplied by publisher]
Source: Interventional Neuroradiology - April 19, 2019 Category: Radiology Tags: Interv Neuroradiol Source Type: research

Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis.
CONCLUSIONS: According to the results of this analysis, DAPT might have to be cautiously be used following PCI in a population of patients with thrombocytopenia at baseline due to the significantly higher bleeding rate including gastro-intestinal, intra-cranial bleeding and hemorrhagic stroke. Hence, special care might have to be taken when considering anti-platelet agents following PCI in these high risk patients. However, considering the present limitations of this analysis, this hypothesis will have to be confirmed in future trials. PMID: 32334636 [PubMed - as supplied by publisher]
Source: BMC Pharmacology and Toxicology - April 27, 2020 Category: Drugs & Pharmacology Tags: BMC Pharmacol Toxicol Source Type: research

Resolute onyx stent more effective than wingspan stent at preventing procedural complications and long-term restenosis
CONCLUSION: R-onyx DES is more effective than WSS in treating sICAD with low rates of periprocedural complications and long-term strokes and symptomatic in-stent restenosis. Future prospective randomized multicenter trials are needed.PMID:35635224 | DOI:10.1177/15910199221104633
Source: Interventional Neuroradiology - May 31, 2022 Category: Radiology Authors: Ameer E Hassan Mohammad Khalil Sohum Desai Wondwossen G Tekle Source Type: research

Stenting in Intracranial Stenosis: Current Controversies and Future Directions
Abstract Angioplasty and stenting for intracranial atherosclerotic stenosis (ICAS) are a last resort for patients with high-grade intracranial stenosis with multiple ischemic events unresponsive to medical therapy. Medical management, consisting of aggressive risk factor control and dual antiplatelet therapy, is superior to angioplasty and stenting for the prevention of future stroke. Future studies of angioplasty and stenting in this population are important, as the stroke risk on medical therapy is 12 % at 1 year and post-procedure stroke rates are similar to rates with medical treatment. There are many issue...
Source: Current Atherosclerosis Reports - June 25, 2015 Category: Cardiology Source Type: research

Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis
Background: Revascularization of stenotic cerebral arteries is hypothesized to improve cognition by increasing cerebral perfusion.Aims: We compared cognition impairment among patients treated with percutaneous angioplasty and stenting (PTAS) and aggressive medical management (AMM) versus AMM alone in the Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis (SAMMPRIS) Trial.Methods: In SAMMPRIS, 451 patients with recent transient ischemic attack or stroke attributed to 70-99% intracranial stenosis were randomized to PTAS plus AMM or AMM alone. Patients who had stroke as the qualifying event with Nat...
Source: Cerebrovascular Diseases - November 8, 2016 Category: Neurology Source Type: research

Current Status and Future Perspective of Stenting for Symptomatic Intracranial Atherosclerotic Disease: A Meta-Analysis.
Abstract The aim of this study was to evaluate the safety and effectiveness of percutaneous transluminal angioplasty and stenting (PTAS) for intracranial atherosclerotic disease (ICAD) by conducting a meta-analysis. Two independent observers searched PubMed, EMBASE, and Cochrane Library for relevant studies up to 31 December 2016. A meta-analysis was conducted using Review Manager 5.3. Three studies involving 581 cases were included. The meta-analysis indicated that any stroke (RR = 3.13; 95% CI: 1.80-5.42), ischemic stroke (RR = 2.15; 95% CI: 1.19-3.89), and intracranial hemorrhage (RR = 14.71; 95% CI: 1.96-110.4...
Source: Biomed Res - July 14, 2017 Category: Research Authors: Li ZH, Zhou ZH, Zhu XJ, Liu W, Chen YW, Chen ZY, Liu ZJ Tags: Biomed Res Int Source Type: research

Outcomes of early carotid stenting and angioplasty in large-vessel anterior circulation strokes treated with mechanical thrombectomy and intravenous thrombolytics.
Conclusions If indicated, it is reasonable to consider concurrent carotid stenting and/or angioplasty for large-vessel anterior circulation stroke patients treated with mechanical thrombectomy who also receive intravenous thrombolytics. PMID: 29697301 [PubMed - as supplied by publisher]
Source: Interventional Neuroradiology - April 28, 2018 Category: Radiology Tags: Interv Neuroradiol Source Type: research

Endovascular treatment for emergent large vessel occlusion due to severe intracranial atherosclerotic stenosis.
CONCLUSIONS Both intracranial angioplasty/stenting and intraarterial infusion of a glycoprotein IIb/IIIa inhibitor are effective and safe in the treatment of underlying severe ICAS in acute stroke patients with ELVO. In addition, a lack of a history of stroke/TIA was the only independent predictor of good outcome after endovascular therapy in such patients. PMID: 29932374 [PubMed - as supplied by publisher]
Source: Journal of Neurosurgery - June 22, 2018 Category: Neurosurgery Authors: Kang DH, Yoon W, Kim SK, Baek BH, Lee YY, Kim YW, Kim YS, Hwang YH, Kim JT, Park MS Tags: J Neurosurg Source Type: research

Submaximal primary angioplasty for symptomatic intracranial atherosclerosis: peri-procedural complications and long-term outcomes
ConclusionSubmaximal primary angioplasty can be performed with a low peri-procedural complication rate and relatively good clinical outcome at long-term follow-up for symptomatic ICAS patients.
Source: Neuroradiology - November 28, 2018 Category: Radiology Source Type: research

A Retrospective Study Comparison Between Stenting and Standardized Medical Treatment for Intracranial Vertebrobasilar Stenosis in a Real-World Chinese Cohort
Conclusions: In a real-world Chinese cohort, PTAS for patients might be superior to SMT, and provide better long-term neurological function recovery and lower disability rate.
Source: Frontiers in Neurology - May 31, 2021 Category: Neurology Source Type: research

E-139 Use of drug-eluding, balloon-expandable resolute onyx coronary stent as a new treatment strategy for vertebral artery ostial stenosis
ConclusionWe report the first clinical series investigating the use of drug-eluding, balloon-expandable Resolute Onyx coronary stent as a safe, efficacious, and durable treatment option for both symptomatic and asymptomatic vertebral ostial stenosis.Disclosures J. Lim: None. A. Baig: None. A. Aguirre: None. A. Monteiro: None. E. Levy: 2; C; : Claret Medical, GLG Consulting, Guidepoint Global, Imperial Care, Medtronic, Rebound, StimMed, Misionix, Mosiac, Clarion, IRRAS.. 4; C; NeXtGen Biologics, RAPID Medical, Claret Medical, Cognition Medical, Imperative Care, Rebound Therapeutics, StimMed, Three Rivers Medical. A. Siddiqu...
Source: Journal of NeuroInterventional Surgery - July 23, 2022 Category: Neurosurgery Authors: Lim, J., Baig, A., Aguirre, A., Monteiro, A., Levy, E., Siddiqui, A. Tags: SNIS 19th annual meeting electronic poster abstracts Source Type: research

Use of drug-eluting, balloon-expandable resolute onyx coronary stent as a novel treatment strategy for vertebral artery ostial stenosis: Case series
CONCLUSIONS: We report the first case series of Resolute Onyx drug-eluting stenting including 30-day postprocedure stroke/TIA rates and clinical/radiographic follow up and demonstrate safe and effective treatment of symptomatic and asymptomatic VA ostial stenosis.PMID:36357368 | DOI:10.1177/15910199221138138
Source: Interventional Neuroradiology - November 10, 2022 Category: Radiology Authors: Jaims Lim Ammad A Baig Alexander O Aguirre Justin M Cappuzzo Kunal Vakharia Kyungduk Rho Muhammad Waqas Andre Monteiro Thomas J Fretz Elad I Levy Adnan H Siddiqui Source Type: research

Hyperacute stenting and angioplasty for acute extracranial non-tandem internal carotid artery strokes within the first 48  h: A 20-year experience and a systematic review and meta-analysis
CONCLUSION: Stenting and angioplasty for acute cervical ICA occlusive strokes during the hyperacute phase can be performed successfully with favorable clinical outcomes and an acceptable recanalization rate.PMID:37218164 | DOI:10.1177/15910199231164510
Source: Interventional Neuroradiology - May 23, 2023 Category: Radiology Authors: Ammad A Baig Pui Man Rosalind Lai Ryan C Turner Brianna M Donnelly Cathleen C Kuo Jaims Lim Kunal P Raygor Mehdi Bouslama Shefalika Prasad Najya Fayyaz Kenneth V Snyder Jason M Davies Adnan H Siddiqui Elad I Levy Source Type: research

O-004 A propensity score-matched comparative study of balloon guide catheters vs conventional guide catheters for mechanical thrombectomy with stenting in tandem strokes: comparison of 1st-pass effect, symptomatic ICH, and 90-day functional outcomes
ConclusionBGCs used for concurrent MT-carotid revascularization with flow arrest were safe and resulted in superior clinical and angiographic outcomes in tandem stroke patients.Abstract O-004 Table 1Multivariate logistic regression analysis performed after propensity score matching to compare procedural parameters and angiographic and clinical outcomes between balloon guide catheter and conventional guide catheter groupsDisclosures A. Baig: None. M. Waqas: None. R. Turner: None. C. Kuo: None. B. Donnelly: None. P. Lai: None. K. Raygor: None. M. Bouslama: None. J. Lim: None. J. Neumaier: None. J. Cappuzzo: None. J. Davies: ...
Source: Journal of NeuroInterventional Surgery - July 30, 2023 Category: Neurosurgery Authors: Baig, A., Waqas, M., Turner, R., Kuo, C., Donnelly, B., Lai, P., Raygor, K., Bouslama, M., Lim, J., Neumaier, J., Cappuzzo, J., Davies, J., Snyder, K., Siddiqui, A., Levy, E. Tags: SNIS 20th annual meeting oral abstracts Source Type: research